Evommune, Inc.

Entity
Company
Industry
Pharmaceutical Preparations (Office Of Life Sciences)
Business address
1841 Page Mill Rd, 94304 Palo Alto, CA
Phone
(650) 223-7745
State of incorporation
DE
Fiscal year end
December 31
Category

Emerging growth company
All SEC filings
View on sec.gov
Get insider transactions for this issuer
Evommune, Inc. has filed 55 SEC EDGAR filings since 1/7/2025

Latest Filings

Form type Document Filing Description Filing date Reporting date File number(s)
SCHEDULE 13G Open Document Open Filing Nov 17, 2025 005-95351
SCHEDULE 13D Open Document Open Filing Nov 17, 2025 005-95351
SCHEDULE 13D Open Document Open Filing Nov 14, 2025 005-95351
4 Open Document Open Filing STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Nov 12, 2025 Nov 7, 2025
4 Open Document Open Filing Nov 12, 2025 Nov 7, 2025
4 Open Document Open Filing Nov 12, 2025 Nov 7, 2025
4 Open Document Open Filing Nov 12, 2025 Nov 7, 2025
4 Open Document Open Filing Nov 12, 2025 Nov 7, 2025
4 Open Document Open Filing Nov 12, 2025 Nov 7, 2025
4 Open Document Open Filing Nov 12, 2025 Nov 7, 2025
4 Open Document Open Filing Nov 12, 2025 Nov 7, 2025
4 Open Document Open Filing Nov 12, 2025 Nov 7, 2025
4 Open Document Open Filing Nov 12, 2025 Nov 7, 2025
4 Open Document Open Filing Nov 12, 2025 Nov 7, 2025
4 Open Document Open Filing Nov 12, 2025 Nov 7, 2025
S-8 Open Document | Data Open Filing S-8 Nov 7, 2025 333-291386
4 Open Document Open Filing Nov 7, 2025 Nov 5, 2025
4 Open Document Open Filing Nov 7, 2025 Nov 5, 2025
4 Open Document Open Filing Nov 7, 2025 Nov 5, 2025
4 Open Document Open Filing Nov 7, 2025 Nov 5, 2025
4 Open Document Open Filing Nov 7, 2025 Nov 5, 2025
4 Open Document Open Filing Nov 7, 2025 Nov 5, 2025
4 Open Document Open Filing Nov 7, 2025 Nov 5, 2025
4 Open Document Open Filing Nov 7, 2025 Nov 5, 2025
8-K Open Document | Data Open Filing 8-K Nov 7, 2025 Nov 7, 2025 001-42938
424B4 Open Document Open Filing 424B4 Nov 6, 2025 333-290793
FWP Open Document Open Filing FWP Nov 6, 2025 333-290793
3 Open Document Open Filing Nov 5, 2025 Nov 5, 2025
3 Open Document Open Filing Nov 5, 2025 Nov 5, 2025
3 Open Document Open Filing INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Nov 5, 2025 Nov 5, 2025
3 Open Document Open Filing Nov 5, 2025 Nov 5, 2025
3 Open Document Open Filing Nov 5, 2025 Nov 5, 2025
3 Open Document Open Filing Nov 5, 2025 Nov 5, 2025
3 Open Document Open Filing Nov 5, 2025 Nov 5, 2025
3 Open Document Open Filing Nov 5, 2025 Nov 5, 2025
3 Open Document Open Filing Nov 5, 2025 Nov 5, 2025
3 Open Document Open Filing Nov 5, 2025 Nov 5, 2025
3 Open Document Open Filing Nov 5, 2025 Nov 5, 2025
3 Open Document Open Filing Nov 5, 2025 Nov 5, 2025
3 Open Document Open Filing Nov 5, 2025 Nov 5, 2025
3 Open Document Open Filing Nov 5, 2025 Nov 5, 2025
3 Open Document Open Filing Nov 5, 2025 Nov 5, 2025
CERT Open Document Open Filing NYSE CERTIFICATION Nov 5, 2025 001-42938
8-A12B Open Document Open Filing 8-A12B Nov 4, 2025 001-42938
FWP Open Document Open Filing FWP Oct 30, 2025 333-290793
S-1/A Open Document | Data Open Filing S-1/A Oct 17, 2025 333-290793
S-1 Open Document | Data Open Filing S-1 Oct 9, 2025 333-290793
DRS/A Open Document Open Filing Sep 23, 2025 377-08010
DRS/A Open Document Open Filing Sep 2, 2025 377-08010
DRS/A Open Document Open Filing Jul 18, 2025 377-08010
DRS Open Document Open Filing May 14, 2025 377-08010
D Open Document Open Filing Jan 8, 2025 021-534546
D Open Document Open Filing Jan 8, 2025 021-534516
D Open Document Open Filing Jan 8, 2025 021-534510
D Open Document Open Filing Jan 7, 2025 021-534380